Standard operating procedure on how to run a safe and effective medicines reuse scheme in a care home or hospice during the coronavirus outbreak. Managing medicines NICE has issued good practice for managing medicines in […]
The families of health and care workers on the frontline in England will benefit from a new life assurance scheme during the coronavirus (COVID-19) pandemic. Published 27 April 2020 New life assurance scheme launched for […]
1.During the pandemic, the principles of the MCA and the safeguards provided by DoLS still apply. This emergency guidance is for all decision-makers in England and Wales who are caring for, or treating, a person […]
RESTORE2TM makes National Early Warning Scores (NEWS2) accessible to care and nursing homes through the use of soft signs of deterioration. It includes a communication and escalation protocol developed with GP’s, ambulance providers and deterioration experts […]
This guidance sets out how Local Authorities can use the new Care Act easements, created under the Coronavirus Act 2020, to ensure the best possible care for people in our society during this exceptional period. […]
Rosemont Pharmaceuticals Ltd has informed us of an error in the barcode and GTIN number of the label on the bottle of the below batches. Published 30 March 2020 From: Medicines and Healthcare products Regulatory […]
25 March 2020 An update for providers of health and social care on the development of a COVID-19 registration framework. We want to support health and social care providers as they look to increase capacity […]
Mylan UK Healthcare Ltd has informed us that the GTIN barcode applied on the above batches is incorrect. The GTIN number that should have been allocated for these batches of capsules is 05060035240173, however, 05060035241477 […]
